Senti Biosciences, Inc.

Nasdaq:SNTI

Biological Products, (No Diagnostic Substances)·SOUTH SAN FRANCISCO, CA

CEO

Lu Timothy K

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

15 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
4/28/25	Q1 FY2025	→
3/20/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
↓

News (8-K)

49 shown

Filed	Type	Description
12/9/25	Reg FD	Regulation FD Disclosure	→
7/18/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/30/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/18/25	Reg FD	Regulation FD Disclosure	→
3/24/25	Agreement	Entry into a Material Definitive Agreement	→
3/10/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
4/30/25	ARS	ARS	→
3/31/25	424B5	424B5	→
3/21/25	S-3	S-3	→
3/21/25	S-3	S-3	→
3/7/25	S-8	S-8	→
5/29/24	ARS	ARS	→
↓

Filing History(306 filings)

TypeDateAccessionPeriodSize

Feb 3, 2026

0001628280-26-005018FORM 4

Feb 2, 2026

5.1 KB

Feb 3, 2026

0001628280-26-005014FORM 4

Feb 2, 2026

6.9 KB

SCHEDULE 13D/A

Jan 20, 2026

0000902664-26-000314

—

11.0 KB

8-K

Dec 9, 2025

0001628280-25-0559538-K

Dec 9, 2025

6.6 MB

10-Q

Nov 13, 2025

0001628280-25-05212510-Q

Sep 30, 2025

7.0 MB

8-K

Nov 13, 2025

0001628280-25-0520838-K

Nov 13, 2025

226.0 KB

SCHEDULE 13D/A

Sep 2, 2025

0000902664-25-003924

—

12.2 KB

10-Q

Aug 7, 2025

0001854270-25-00009010-Q

Jun 30, 2025

6.8 MB

8-K

Aug 7, 2025

0001854270-25-0000888-K

Aug 7, 2025

228.5 KB

Jul 21, 2025

0001854270-25-000083FORM 4

Jul 18, 2025

5.5 KB

Jul 21, 2025

0001854270-25-000081FORM 3

Jul 18, 2025

479.8 KB

8-K

Jul 18, 2025

0001854270-25-0000778-K

Jul 18, 2025

198.9 KB

8-K

Jun 30, 2025

0001854270-25-0000738-K

Jun 25, 2025

150.7 KB

Jun 27, 2025

0000950170-25-0911584

Jun 25, 2025

5.4 KB

Jun 27, 2025

0000950170-25-0911574

Jun 25, 2025

5.4 KB

Jun 27, 2025

0000950170-25-0911554

Jun 25, 2025

5.4 KB

Jun 27, 2025

0000950170-25-0911544

Jun 25, 2025

5.4 KB

Jun 27, 2025

0000950170-25-0911504

Jun 25, 2025

5.4 KB

Jun 27, 2025

0000950170-25-0911344

Jun 25, 2025

5.4 KB

8-K

Jun 18, 2025

0001854270-25-0000698-K

Jun 18, 2025

176.9 KB

SCHEDULE 13G/A

May 15, 2025

0001104659-25-049546

—

7.8 KB

SCHEDULE 13G/A

May 15, 2025

0001104659-25-049539

—

11.3 KB

SCHEDULE 13G/A

May 15, 2025

0001104659-25-049516

—

11.3 KB

SCHEDULE 13G/A

May 15, 2025

0001172661-25-002300

—

10.6 KB

SCHEDULE 13G/A

May 7, 2025

0000950170-25-065736

—

13.7 KB

25 filings shown

Senti Biosciences, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(306 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/30/25	DEFA14A	DEFA14A	→
4/30/25	DEF 14A	DEFINITIVE PROXY	→
1/27/25	DEF 14A	DEF 14A	→
1/15/25	PRE 14A	PRE 14A	→
5/29/24	DEFA14A	DEFA14A	→
5/29/24	DEF 14A	DEFINITIVE PROXY	→
↓

Filed	Form	Description
2/3/26	4	4	→
2/3/26	4	4	→
7/21/25	4	4	→
7/21/25	3	FORM 3	→
6/27/25	4	4	→
6/27/25	4	4	→
↓

Filed	Form	Description
1/20/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
9/2/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓